Safety of liver resection in patients receiving antithrombotic therapy: A systematic review of the literature

doi:10.4254/wjh.v13.i7.804

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3671)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

227

WORD

120

HTML

1892

Figures (1-2)

189

Tables (1-3)

218

Sum=2646

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

352

Download

673

Sum=1025

Jul 27, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Hepatol. Jul 27, 2021; 13(7): 804-814
Published online Jul 27, 2021. doi: 10.4254/wjh.v13.i7.804

Safety of liver resection in patients receiving antithrombotic therapy: A systematic review of the literature

Takahisa Fujikawa

Takahisa Fujikawa, Department of Surgery, Kokura Memorial Hospital, Fukuoka 802-8555, Japan

Author contributions: Fujikawa T designed and performed research, and analyzed data; Fujikawa T prepared a manuscript and reviewed it.

Conflict-of-interest statement: The authors report no relevant conflicts of interest.

Data sharing statement: No additional data are available.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Takahisa Fujikawa, FACS, MD, PhD, Chief Doctor, Department of Surgery, Kokura Memorial Hospital, 3-2-1 Asano, Kitakyushu, Fukuoka 802-8555, Japan. fujikawa-t@kokurakinen.or.jp

Received: March 5, 2021
Peer-review started: March 5, 2021
First decision: May 2, 2021
Revised: May 7, 2021
Accepted: July 2, 2021
Article in press: July 2, 2021
Published online: July 27, 2021

Core Tip

Core Tip: A total of 16 published articles on antithrombotic therapy and hepatectomy have been reviewed systematically. The articles showed that the risk of thromboembolic and/or bleeding events in patients with continued preoperative aspirin was not different from those in patients with no antithrombotic or interrupted antiplatelet drugs, although pharmacological prophylaxis of venous thromboembolism is still controversial, especially when performing hepatectomy in Asian patient populations.